The JAK-STAT pathway is also known to be over-activated in various cancers, including CTCL, and contributes to malignant cell proliferation and survival (Brooks and Putoczki, 2020). This evidence concerns the gene SOAT1 and primary cutaneous T-cell non-Hodgkin lymphoma.